⌘K
Loading ticker…
As of 2026-08-24, AstraZeneca PLC (AZN) has a 3-month relative strength percentile of 29 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 59. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 1.8%, relative volume 0.63×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
AZN is in a stage 3 topping pattern, week 2. Currently in a 130-day base; basing ADR 1.8% (broad 1.7%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: -3.0% / 5.9%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.
AZN appears in 1 ETF as of Jun 2026: PRVS at 4.84% weight, $1M notional.
Held by 32 ETFs · $391M across latest filings · largest weight 5.71% (MEDX).
Top 1 by value, from SEC N-PORT-P filings dated Jun 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| PRVS | 4.84% | $1M | −1.24 pp |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AZN Jan avg: 1.07% median: -0.07% win: 50% σ: 4.97% n: 4 2022-04-12 → 2026-07-31 | AZN Feb avg: 32.10% median: 3.71% win: 50% σ: 61.92% n: 4 2022-04-12 → 2026-07-31 | AZN Mar avg: 0.78% median: 1.02% win: 50% σ: 6.13% n: 4 2022-04-12 → 2026-07-31 | AZN Apr avg: 0.84% median: -2.33% win: 40% σ: 7.70% n: 5 2022-04-12 → 2026-07-31 | AZN May avg: 0.66% median: 0.12% win: 60% σ: 1.48% n: 5 2022-04-12 → 2026-07-31 | AZN Jun avg: -0.93% median: -0.62% win: 20% σ: 2.31% n: 5 2022-04-12 → 2026-07-31 | AZN Jul avg: -0.81% median: 0.24% win: 80% σ: 5.73% n: 5 2022-04-12 → 2026-07-31 | AZN Aug avg: 2.20% median: 1.95% win: 50% σ: 9.04% n: 4 2022-04-12 → 2026-07-31 (current) | AZN Sep avg: -6.82% median: -7.53% win: 0% σ: 5.73% n: 4 2022-04-12 → 2026-07-31 | AZN Oct avg: -0.17% median: 0.30% win: 50% σ: 8.69% n: 4 2022-04-12 → 2026-07-31 | AZN Nov avg: 6.32% median: 7.34% win: 75% σ: 9.47% n: 4 2022-04-12 → 2026-07-31 | AZN Dec avg: 0.02% median: -0.55% win: 25% σ: 3.09% n: 4 2022-04-12 → 2026-07-31 |